Rituximab in idiopathic nephrotic syndrome: does it make sense?
about
Biologic agents in the treatment of glomerulonephritides.B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome.Unsuccessful Treatment with Abatacept in Recurrent Focal Segmental Glomerulosclerosis after Kidney Transplantation.Variability of diagnostic criteria and treatment of idiopathic nephrotic syndrome across European countries.
P2860
Rituximab in idiopathic nephrotic syndrome: does it make sense?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rituximab in idiopathic nephrotic syndrome: does it make sense?
@en
Rituximab in idiopathic nephrotic syndrome: does it make sense?
@nl
type
label
Rituximab in idiopathic nephrotic syndrome: does it make sense?
@en
Rituximab in idiopathic nephrotic syndrome: does it make sense?
@nl
prefLabel
Rituximab in idiopathic nephrotic syndrome: does it make sense?
@en
Rituximab in idiopathic nephrotic syndrome: does it make sense?
@nl
P2093
P2860
P1433
P1476
Rituximab in idiopathic nephrotic syndrome: does it make sense?
@en
P2093
Christopher Rivard
Eduardo H Garin
Gabriel Cara-Fuentes
John A Kairalla
Richard J Johnson
Takuji Ishimoto
P2860
P2888
P304
P356
10.1007/S00467-013-2534-4
P577
2013-06-23T00:00:00Z